These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11427226)

  • 1. Effects of gender, hepatic lipase gene polymorphism and type 2 diabetes mellitus on hepatic lipase activity in Chinese.
    Tan KC; Shiu SW; Chu BY
    Atherosclerosis; 2001 Jul; 157(1):233-9. PubMed ID: 11427226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin dose-dependently decreases hepatic lipase activity in type 2 diabetes: effect of sex and the LIPC promoter variant.
    Berk-Planken II; Hoogerbrugge N; Stolk RP; Bootsma AH; Jansen H;
    Diabetes Care; 2003 Feb; 26(2):427-32. PubMed ID: 12547874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hepatic lipase gene promoter polymorphism attenuates the increase in hepatic lipase activity with increasing intra-abdominal fat in women.
    Carr MC; Hokanson JE; Deeb SS; Purnell JQ; Mitchell ES; Brunzell JD
    Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2701-7. PubMed ID: 10559014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol.
    Zambon A; Deeb SS; Hokanson JE; Brown BG; Brunzell JD
    Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1723-9. PubMed ID: 9812910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low/high density lipoprotein heterogeneity.
    Carr MC; Hokanson JE; Zambon A; Deeb SS; Barrett PH; Purnell JQ; Brunzell JD
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2831-7. PubMed ID: 11397895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between the -514C->T polymorphism of the hepatic lipase gene and lifestyle factors in relation to HDL concentrations among US diabetic men.
    Zhang C; Lopez-Ridaura R; Rimm EB; Rifai N; Hunter DJ; Hu FB
    Am J Clin Nutr; 2005 Jun; 81(6):1429-35. PubMed ID: 15941898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus: the Finnish Diabetes Prevention Study.
    Todorova B; Kubaszek A; Pihlajamäki J; Lindström J; Eriksson J; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M; Laakso M;
    J Clin Endocrinol Metab; 2004 May; 89(5):2019-23. PubMed ID: 15126514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators.
    Tahvanainen E; Syvanne M; Frick MH; Murtomaki-Repo S; Antikainen M; Kesaniemi YA; Kauma H; Pasternak A; Taskinen MR; Ehnholm C
    J Clin Invest; 1998 Mar; 101(5):956-60. PubMed ID: 9486964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary fat intake determines the effect of a common polymorphism in the hepatic lipase gene promoter on high-density lipoprotein metabolism: evidence of a strong dose effect in this gene-nutrient interaction in the Framingham Study.
    Ordovas JM; Corella D; Demissie S; Cupples LA; Couture P; Coltell O; Wilson PW; Schaefer EJ; Tucker KL
    Circulation; 2002 Oct; 106(18):2315-21. PubMed ID: 12403660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The G-250A substitution in the promoter region of the hepatic lipase gene is associated with the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
    Zacharova J; Todorova BR; Chiasson JL; Laakso M;
    J Intern Med; 2005 Feb; 257(2):185-93. PubMed ID: 15656877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A common promoter polymorphism in the hepatic lipase gene (LIPC-480C>T) is associated with an increase in coronary calcification in type 1 diabetes.
    Hokanson JE; Cheng S; Snell-Bergeon JK; Fijal BA; Grow MA; Hung C; Erlich HA; Ehrlich J; Eckel RH; Rewers M
    Diabetes; 2002 Apr; 51(4):1208-13. PubMed ID: 11916946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between cholesteryl ester transfer protein and hepatic lipase encoding genes and the risk of type 2 diabetes: results from the Telde study.
    López-Ríos L; Nóvoa FJ; Chirino R; Varillas F; Boronat-Cortés M; Wägner AM
    PLoS One; 2011; 6(11):e27208. PubMed ID: 22073289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hepatic lipase -514C->T polymorphism and its interactions with apolipoprotein C3 -482C->T and apolipoprotein E exon 4 polymorphisms on the risk of nephropathy in chinese type 2 diabetic patients.
    Baum L; Ng MC; So WY; Lam VK; Wang Y; Poon E; Tomlinson B; Cheng S; Lindpaintner K; Chan JC
    Diabetes Care; 2005 Jul; 28(7):1704-9. PubMed ID: 15983323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients.
    Jansen H; Verhoeven AJ; Weeks L; Kastelein JJ; Halley DJ; van den Ouweland A; Jukema JW; Seidell JC; Birkenhäger JC
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2837-42. PubMed ID: 9409263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic lipase (LIPC) C-514T gene polymorphism is associated with cardiometabolic parameters and cardiovascular risk factors but not with fatty liver in Mexican population.
    Posadas-Sánchez R; Ocampo-Arcos WA; López-Uribe ÁR; Posadas-Romero C; Villarreal-Molina T; León EÁ; Pérez-Hernández N; Rodríguez-Pérez JM; Cardoso-Saldaña G; Medina-Urrutia A; Vargas-Alarcón G
    Exp Mol Pathol; 2015 Feb; 98(1):93-8. PubMed ID: 25550127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation in the hepatic lipase gene and the risk of coronary heart disease among US diabetic men: potential interaction with obesity.
    Zhang C; Lopez-Ridaura R; Rimm EB; Li T; Hunter DJ; Hu FB
    Diabetologia; 2006 Jul; 49(7):1552-9. PubMed ID: 16570154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association of the hepatic lipase gene -250G/A promoter polymorphism with the susceptibility to type 2 diabetes mellitus combining with coronary heart disease].
    Wei M; Lu YS; Li PP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):219-22. PubMed ID: 19350521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of association between genetic variation in the LIPC gene promoter and plasma lipoproteins in three Canadian populations.
    Hegele RA; Harris SB; Brunt JH; Young TK; Hanley AJ; Zinman B; Connelly PW
    Atherosclerosis; 1999 Sep; 146(1):153-60. PubMed ID: 10487498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the G-250A promoter polymorphism in the hepatic lipase gene with the risk of type 2 diabetes mellitus.
    Ou L; Yao L; Guo Y; Fan S
    Ann Endocrinol (Paris); 2013 Feb; 74(1):45-8. PubMed ID: 23351562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The G-250A polymorphism in the hepatic lipase gene promoter is associated with changes in hepatic lipase activity and LDL cholesterol: The KANWU Study.
    Lindi V; Schwab U; Louheranta A; Vessby B; Hermansen K; Tapsell L; Riccardi G; Rivellese AA; Laakso M; Uusitupa MI;
    Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):88-95. PubMed ID: 17327141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.